Novo Nordisk A/S ADR buy StockNews.com
Start price
29.12.24
/
50%
€84.40
Target price
29.12.25
-
Performance (%)
-50.36%
Price
05.08.25
€40.80
Summary
This prediction is currently active. The BUY prediction by StockNews_com for Novo Nordisk A/S ADR is performing very badly with a performance of -50.36%. Dividends of €1.10 are taken into consideration when calculating the performance. This prediction currently runs until 29.12.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -12.727% | -12.727% |
| iShares Core DAX® | -1.351% | 0.610% |
| iShares Nasdaq 100 | -1.453% | 3.019% |
| iShares Nikkei 225® | -0.021% | 1.195% |
| iShares S&P 500 | -1.326% | 2.830% |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat
Stopped prediction by StockNews_com for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€102.50
14.12.24
14.12.24
-
14.12.25
14.12.25
-59.12%
05.08.25
05.08.25
